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The folding and cyclization of poly-b-carbonyl chains controlled by 
the intricate enzymatic polyketide synthase machinery results in 
a remarkable diversity of aromatic natural products. Synthetic 
methods that allow for the preparation of highly reactive 
polyketide chains and control over their folding in ensuing 
cyclizations likewise lead to versatile divergent preparations of 
aromatic scaffolds valuable for numerous applications. Although 
biomimetic polyketide cyclizations have repeatedly been applied 
in the total synthesis of polyphenol natural products, their 
prospects for the preparation of the broad range of polyaromatic 
architectures has yet to reach its full potential. This review 
highlights some of the virtues of applying polyketide logic for the 
retrosynthetic analysis of polycyclic aromatic scaffolds, the 
increasing accessibility of precursors and the potential of small-
molecule catalysts for controlling polyketide cyclizations to 
provide polyaromatic scaffolds. 
1. Introduction 
Aromatic polyketides are a vast group of structurally, biogen-
etically and pharmacologically intriguing natural products, isolated 
from bacteria, fungi and plants.[1] Several compounds of this class 
of natural products are indispensable for human medicine, for 
instance in the treatment of cancer and bacterial infections (e.g. 
tetracycline and doxorubicin, Figure 1a) while others have a great 
potential as novel drug candidates in medicinal chemistry 
campaigns. Intriguingly, the structural diversity of the aromatic 
core structures originates from common poly-b-carbonyl chain 
intermediates, which are assembled, processed, preorganized by 
their folding and cyclized by the intricate polyketide synthase 
(PKS) enzymatic machinery.[2] By optional tailoring processes, the 
aromatic systems are often further differentiated by methylation, 
amination, oxidation and glycosylation steps.[3] In addition to the 
various linear and angular aromatic systems, atropisomeric 
aromatic scaffolds, typically produced by oxidative phenol 
couplings of aromatic systems, are frequently encountered (e.g. 
(Sa)-ustalaginoidin A).[4] Recently, a new class of aromatic 
polyketide was isolated, suggesting a preorganizing folding that 
results in an atroposelective polyketide cyclization leading to 
enantioenriched biaryl entities (e.g. fasamycin C).[5] Considering 
the retrosynthesis of polyaromatic scaffolds in view of polyketide 
biosynthesis, synthetically derived poly-b-carbonyl chains 
epitomize the ideal substrates for accessing a diverse set of 
aromatic scaffolds (Scheme 1c). Biomimetic keto-processing of 
the poly-b-carbonyl intermediates by selective carbonyl 
reductions and control over folding modes to guide corresponding 
aldol or Claisen cyclizations, enable the preparation of numerous 
aromatic scaffolds bearing different oxygenation patterns and 
topologies.[6]  Over the years, polyketide cyclizations have 
become a valuable synthetic strategy for the biomimetic 
preparation of natural products, where the folding modes are 
controlled by preorganized substrates in order to assemble 
suitable aromatic core structures. Recently, small-molecule 
catalysts have been applied to control stereoselective aldol 
condensations to provide atropisomeric aromatic scaffolds related 
to the biogenesis of aromatic polyketides. Catalytic polyketide 
cyclizations thus hold great promise for constructing novel 


























Figure 1: a) Selected aromatic polyketides used as antibiotics and cancer 
therapeutics. b) Atropisomeric polyketide natural products. c) Retrosynthesis of 
polyaromatic scaffolds by applying the logic of polyketide biosynthesis to identify 
conceivable pentaketide precursors, optional keto-processing, and the folding 
for the ensuing aldol-, Knoevenagel-, and Claisen-cyclization processes. 
2. Biosynthesis of Aromatic Polyketides 
Polyketide synthases (PKSs) are multi-enzyme complexes that 
assemble a broad range of natural products including aromatic 
polycycles, macrolides, polyenes and polyethers.[2] Based on their 
architecture and mode of action, PKSs can be classified into 
modular type I, and iterative type I, II and III. The iterative type I 
PKSs are further divided into the subgroups of highly reducing 
(HR-), partially reducing (PR-) and non-reducing (NR-) PKSs. 
Aromatic polyketide scaffolds are typically provided by type II, 
iterative type I NR- as well as PR- and type III PKSs.  
These aromatic PKSs catalyze the iterative assembly of acetate 
C2 synthons (typically condensation of malonyl units, 2) onto a 
specific starter unit (primer, 1) leading to poly-b-carbonyl chain 
intermediates (phase I in Scheme 1, 3, 4). The folding and 
cyclizations of these highly reactive chains controlled by the 
enzymatic machinery result in the formation of the corresponding 
aromatic core structures (phase II, 5, 6), which are typically further 
diversified by tailoring processes involving methylation, oxidation 
and glycosylation steps (phase III, rabelomycin and 
rubrofusarin).[3]  
[a] V. C. Fäseke, F. C. Raps, Prof. Dr. C. Sparr 
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Scheme 1: Proposed biosynthesis of an angulamycin (rabelomycin) by type II 
PKSs of bacteria and of nor-rubrofusarin by type I NR-PKSs of fungi.  
 
The bacterial aromatic polyketide biosynthesis is mainly governed 
by type II PKSs, which comprise an accumulation of dissociated 
mono-functional enzymes (Scheme 1).[7] The poly-b-carbonyl 
chain is constructed by the minimal PKS, which consists of the 
heterodimeric keto-synthase (KSa+KSb), malonyl CoA-acyl carrier 
protein transacylase (MAT) and the acyl carrier protein (ACP). 
Here, the length of the assembled chain is controlled by the 
KSb (chain length factor).[8] In bacteria, keto-processing of the 
nascent polyketide chain is performed by keto-reductases leading 
for instance to the regioselective C9-carbonyl reduction leading to 
a loss of oxygen, which is frequently observed in the oxidation 
pattern of tetracyclines, anthracyclines and angucyclines. The KR 
as well as the KSb are proposed to already initiate the first 
cyclization leading to the selective C7-C12 aldol cyclization, which 
are then further selectively cyclized by cyclases/aromatases 
(CYCs/AROs).[9] 
In fungi, the aromatic polyketide biosynthesis is mainly 
accomplished by megasynthases consisting of multiple functional 
tethered domains, however without KR domains (iterative type I 
NR-PKSs, Scheme 1).[10] The truly remarkable progress in the 
understanding and engineering of PKSs furthermore allows to 
recognize the minimal PKS, built of an keto-synthase (KS), 
malonyl specific acyltransferase (MAT) and the ACP.[10,11] Beside 
the non-reducing nature of the type I NR-PKSs different to the 
type II PKSs, the regioselective cyclizations of the nascent 
polyketide chain are initiated and controlled by the product 
template domain (PT) as well as the thioesterase (TE).[12]  
 
The PT typically mediates multiple aldol cyclizations in its single 
active cavity, which then is often followed by a Claisen cyclization 
controlled by the TE to release the aromatic product from the 
megasynthase. Beside these two PKS systems producing large 
aromatic polyketide core structures, the partially reducing 
subgroup of type I PKSs found in bacteria (type I PR-PKSs) 
produce smaller aromatic systems (up to naphthoic acid).[13] With 
the incorporated KR domains in the megasynthase, multiple 
selective keto-reductions of the assembled polyketide chain lead 
to aromatic scaffolds with a reduced level of oxygenation. In 
contrast, type III PKSs are mainly found in plants and consist of a 
homodimer KS that performs a limited number of polyketide chain 
elongations without keto-reduction and directly mediates the 
corresponding regioselective cyclizations.[14] The highly reactive 
polyketide chains assembled by PKSs are prone to spontaneous 
cyclizations and therefore, the immediate folding and the 
subsequent regioselective cyclizations controlled by the enzymes 
are assumed to be essential for the efficient construction of 
aromatic fused ring systems.[15] Here, the initial enzyme-
controlled cyclization of the polyketide chains results in specific 
cyclization patterns, which allows to differentiate the aromatic 
core structures formed by bacteria or fungi. According to these 
distinct initial cyclizations, a classification of aromatic polyketides 
into the folding mode F (fungi, 10) and folding mode S 
(streptomyces, 9) has empirically been established 
(Scheme 2).[16]  
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When the initial benzene ring contains three intact acetyl C2 units 
(7→9), the aromatic polyketide follows the bacterial folding mode 
S. Contrary, with the incorporation of two intact acetyl C2 units (8
→10), the aromatic fused-ring system is classified as the fungal 













Scheme 2: Concept of the initial cyclization leading to either the folding mode 
S (Streptomyces, bacteria) and folding mode F (fungi). 
 
In addition to the diversity of aromatic systems generated by the 
PKSs assembly-line processes, tailoring steps such as oxidative 
transformations allow for new ring topologies, for instance 
resulting from oxidative rearrangements.[3h]  In contrast, oxidative 
phenol coupling reactions of previously folded and cyclized 
aromatic polyketides often result in tetra- or tri-ortho substituted 
biaryls with a restricted rotation about the newly formed C–C bond. 
These atropisomeric scaffolds are frequently found in aromatic 
polyketide products such as ustilaginoidin A (Figure 1b), (Sa)-
orlandin or (Ra)-desertorin A (Scheme 3).[17] In biosynthetic 
oxidative phenol coupling processes, oxidative enzymes 
(OxyEnz) such as laccase, peroxidase or cytochrome P450 
enzymes (CYP) are commonly involved.[3] The additional 
diversification of these unique stereoisomeric scaffolds can be 
guided by dirigent proteins that control regio- and 
stereoselectivity.[18] For instance, from 7-demethylsiderin, 
divergent oxidative regioselective dimerization by either the CYP 
KtnC or DesC led to the enantioselective synthesis of (+)-orlandin 











Scheme 3: Regio- and enantioselective oxidative biaryl coupling catalyzed by 
cytochrome P450 enzymes (CYP). The aromatic pentaketide 7-demethylsiderin 
is converted either into (Sa)-orlandin or (Ra)-desertorin A.  
 
However, a recently reported class of tridecaketides emerging 
from a distinctive fold (11) indicates an alternative biosynthetic 
process for the stereoselective construction of atropisomeric 
biaryl natural products (Scheme 4).[5] In contrast to the 
stereoselective oxidative phenol coupling, the proposed 
biosynthetic pathway suggests an atroposelective aldol 
cyclization controlled by cyclases. According to the biosynthetic 
gene cluster, the hypothetical biosynthetic pathway follows the 
typical first three cyclizations of the decaketide tetracenomycins 
and the related angularly cyclized dodecaketides (C9–C14, C7–
C16 and C5–C18). After these three cyclizations, a branching 
point is reached and the additional acetyl C2 unit in combination 
with a putative cyclase/aromatase enables the cyclization of C25–
C20. The subsequent proposed fifth cyclase then performs the 
last cross-linking of the C2–C19 in a stereoselective fashion. Final 
enzyme-controlled tailoring processes including methylation, 
decarboxylation and oxidation provide the enantioenriched, tri-










Scheme 4: Proposed folding and cyclization mode of the tridecaketide leading 
to the formation of the atropisomeric fasamycin C (4). 
 
3. Polyketide Cyclizations for the Synthesis of 
Aromatic Compounds 
 
In 1893, J. N. Collie discovered the formation of orcinol after 
treatment of dimethylpyrone (12) under basic conditions and 
proposed the biosynthetic hypothesis that oxygenated aromatic 
natural products are assembled from poly-b-carbonyl chains 
derived from the condensation of acetic acid units 
(Scheme 5).[19,20] This hypothesis was later reexamined by Sir R. 






Scheme 5: Collie’s biomimetic synthesis of orcinol from dimethylpyrone. 
 
A. J. Birch, a former co-worker of Sir. R. Robinson, underpinned 
this biosynthetic hypothesis by feeding fungi with 14C labelled 
acetate, which resulted in the isolation of aromatic natural 
products with the polyketide-specific labelling pattern.[22] In 1963, 
Birch and co-workers reported an elegant first synthetic 
preparation of linear penta-b-carbonyl chains and emphasized the 
potential of these biomimetic substrates for the preparation of 
various aromatic products by aldol cyclizations.[23]  
To enable the preparation of the highly reactive intermediates to 
investigate polyketide cyclizations, Money and Scott studied the 
in situ synthesis from stable pyrone precursors (Scheme 6a).[24] 
With the pyranopyrone as a mimic of a tetraketide, stoichiometric 
amounts of aqueous potassium hydroxide resulted in an aldol 
cyclization to the fungi-derived natural product orsellinic acid. In 
contrast, magnesium methoxide in methanol triggered a Claisen 
cyclization to form acylphloroglucinol. Similar results were 
obtained by Crombie and James, who proposed that the methyl 
ester functionality and the chelation of Mg2+ leads to an ideal 
substrate preorganization (14) to favor a Claisen condensation.[25] 











































































































involvement of ketene intermediates (16) formed from pyrone 
substrates (15) to explain the high selectivity observed in Claisen 
cyclizations of a phenyl substituted pyrone-masked tetraketide 






















Scheme 6: a) Initial investigations of polyketide cyclizations of tetraketide 
substrates generated from a pyrone precursor. b) Selective conversion of the 
pyron protected phenyl tetraketide substrate.  
 
In contrast to the pyrone-masked biomimetic polyketide 
precursors, Harris and co-workers prepared stabilized poly-b-
carbonyl substrates such as the phenyl substituted pentaketide 
substrate 17 by utilizing Claisen condensations with polyanion 
species (Scheme 7).[26b,c] Beside the selective formation of the 
pyrone 18 by activation of the carboxylic acid with acetic 
anhydride, the divergent preparation of either the folding mode F 
(19) or S (20) product was accomplished with stoichiometric 
amounts of reagents under neutral or basic conditions. The 
selectivity obtained for the two polyketide cyclizations is proposed 















Scheme 7: Pioneering studies by Harris and co-workers for the 
regioselective cyclization of the phenyl pent-β-carbonyl substrate to a 
pyrone and either the folding mode F or S product. 
 
 
An increased scope for polyaromatic products upon controlling 
multiple polyketide cyclizations requires poly-b-carbonyl 
substrates with more than five carbonyl functionalities. Reducing 
the complexity of cyclizations while increasing the stability of the 
substrates was accomplished with symmetric substrates that 
contain protecting groups. Harris and co-workers thus developed 
polyanion Claisen condensations sequences to access a broad 
range of natural products derived from protected and reduced 
hepta-b-carbonyl substrates (Scheme 8).[27] Manipulation of the 
central carbonyl group by an acetal protecting group resulted in 
the formation of the anthraquinones emodine by a sequential 
process over four steps. The protected hepta-b-carbonyl 
substrate was prepared by a Weiler-type process,[27c]  but could 
not be isolated as it readily converts by a two-fold aldol cyclization. 
In both cases, a highly regioselective third aldol cyclization was 
subsequently obtained and by the installation of two terminal 
acetal protecting groups, the desired substrate for the preparation 
of the natural product eleutherinol was isolated, although in 
moderate yield. These results demonstrate the level of control for 
the folding of poly-b-carbonyl substrates feasible by the 
introduction of suitable protecting groups and the use of 






















Scheme 8: Protecting group strategies for the selective preparation of the 
natural products emodine and eleutherinol. 
An elegant iterative methodology for the biomimetic preparation 
of polycyclic polyoxygenated aromatic compounds was 
implemented by Yamaguchi and co-workers (Scheme 9).[28] The 
dual Claisen condensation of various diesters (23) with 
acetoacetate dianion (24) results in polyketide intermediates, 
which proceed by a twofold aldol cyclization to form two new 
aromatic rings mediated by calcium acetate at high temperatures. 
In a stepwise process, up to pentacyclic aromatic core structures 
(25–27) were accessible and the regioselectivity of the aldol 
cyclizations were found to be substrate-controlled. This 
methodology was subsequently utilized for the aromatic core 
structure synthesis of several polyketide natural products, such 
as urdamicynone B, nanaomycin A or aklavinone and linearly and 
angularly fused pentacyclic core structures. Moreover, elegant 
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polyketide cyclizations can be combined with a cationic polyene 
cyclization to generate the meroterpenoid natural products (+)-

















Scheme 9: Preparation of naphthalenoid derivatives following a twofold aldol 
cyclization process of a reduced hepta-b-carbonyl substrate.  
 
To prepare particularly complex aromatic polyketides, Krohn and 
co-workers started from an anthrone precursor 28 to synthetically 
elaborate the installation of two polycarbonyl appendages that 
induce the folding mode F (Scheme 10, 29).[30] With the removal 
of the C19 carbonyl, the twofold aldol condensation selectively 
proceeds to the angular aromatic dodecaketide core structure 30, 

















Scheme 10: Biomimetic approach towards the preparation of pradimicin A.  
A milder synthesis of poly-b-carbonyl substrates by the Birch 
strategy[23,30] was utilized by Bringmann and co-workers for the 
preparation of partially reduced and protected penta-b-carbonyl 
substrates (31, 33, Scheme 11).[31] Notably, the in situ generated 
substrates 31 and 33 were converted into two putative precursors 
(32, 34) involved in the biosynthesis of the atropisomeric 
ancistrocladeine. The initial polyketide cyclization was triggered 
by SiO2, inducing a cascade process to provide the corresponding 
isoquinoline 32 and naphthalene core structure 34. Interestingly, 
a stereo- and regioselective oxidative phenol coupling of these 


















Scheme 11: Polyketide cyclizations to isoquinoline and the corresponding 
napthalene intermediate towards the total synthesis of ancistrocladeine.  
4. Atroposelective Polyketide Cyclizations  
To emulate a stereoselective arene-forming aldol condensation 
observed in the biosynthesis several rotationally restricted natural 
products, our group developed a polyketide cyclization catalyzed 
by small molecule catalysts for the construction of various 
atropisomeric scaffolds (Scheme 12 cf. Scheme 4).[32]  With 
substrates poised for a polyketide cyclization (35) and an 
activation with suitable catalysts, such as the tetrazole derivative 
of L-proline, an efficient stereoselective formation of 
configurationally stable tri-ortho-substituted biaryls (36, 37) and 


















Scheme 12: The enantioselective arene-forming aldol condensation for the 
preparation of the tri-ortho substituted biaryls (36) and atropisomeric aromatic 
amides (37). SMC: small molecule catalyst. 
 
Captivatingly, the transfer of this synthetic strategy from 
polyketide biosynthesis to small-molecule catalysis provided a 
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interesting molecular architectures (Scheme 13).[33] The catalyst-
controlled aldol condensation followed by the addition of a 
building block (BB) and in situ oxidation allowed the iterative 
assembly of configurationally stable, atropisomeric multi-axis 
systems that formally represent polyketide folds (shown in red). 
Each stereogenic axis of the oligo-1,2-naphthylene (38–40) is 
thereby individually controlled by the small-molecule catalysts, 
offering an entry into structurally distinct and well-defined 
molecular scaffolds. Recognizing the prospects of polyketide 
cyclizations for other fields of application therefore appears as 
valuable consideration for the retrosynthetic analysis of 
























Scheme 13: Stereodivergent synthesis of atropisomeric multiaxis systems by 
iterative arene-forming aldol condensations controlled by small-molecule 
catalysts (SMC). BB: building block.  
5. Noncanonical Polyketide Cyclization 
An oxygenation pattern different from prototypical polyketide 
natural products (≠β) was recently observed in noncanonical 
furan derivatives biosynthesized by cryptic polyketide path-
ways.[34] While this class of polyketides is highly unusual, early 
investigations by Eiden established a synthesis of 1,2-diketo 
fused substrate from oxalic acid diester (41) and their 
transformation into noncanonical 2,2’-pyrone derivatives 








Scheme 14: Synthesis of 2,2’-bipyrones (42) from noncanonical hexa-b-
carbonyl substrate. 
 
Notably, the use of small-molecule catalysts in place of polyketide 
synthases also allows to study catalyst-controlled polyketide 
cyclizations of noncanonical substrates. For instance, a 1,2-
dicarbonyl motif incorporated in a suitable polyketide chain allows 
to access aromatic polyketide biaryls that are different from 
oxidative dimerization products. Our studies were therefore 
focused on hexa-carbonyl substrates with two possible folding 
modes, leading to 5-enolexo or 6-enolendo exo-trig 
aldolizations.[36] Captivatingly, a twofold arene-forming aldol 
condensation thereby gives access to particularly challenging 
tetra-ortho-substituted binaphthalenes with the 3,3'-oxygenation 
pattern, which is exceptionally valuable to shield reactive centers 
within a topologically well-defined scaffold. In accord to the 
pioneering strategies by Birch[23] and Bringmann[31], a mild 
substrate preparation by a fourfold ozonolysis of readily available 
biindene precursors allowed the installation of up to six carbonyl 
functionalities in a single step. The resulting dialdehyde 
substrates (43, R=CHO) were subsequently activated by a 
catalyst that allows for an extended hydrogen bond network, thus 
controlling the aldolization mode and the stereoselectivity of the 
process for biaryls 44. The utility of the products was recognized 
by the stereoselective preparation of catalysts, ligands and 
enantioenriched helicenes, which further underscore the assets 
of polyketide cyclizations for the assembly polyaromatics, also 












Scheme 15: Noncanonical polyketide cyclization for the atroposelective 
preparation of tetra-ortho-substituted biaryls (44) by a twofold aldol cyclization 
controlled by a chiral small-molecule catalyst (SMC). 
6. Conclusion 
By following the biosynthetic principles of polyketide assembly, 
various polycyclic aromatic compounds are accessible by 
captivating and efficient synthetic strategies. The retrosynthetic 
identification of the polyketide pattern thus permits to design 
synthetic methods not only for the total syntheses of natural 
products, but also for topologically unique molecular architectures 
valuable for otherwise unrelated applications. Next to polyketide 
cyclizations to construct the polyaromatic core structures of 
pharmacologically valuable natural products and derivatives, 
catalyst scaffolds and helical polyaromatics are readily accessible 
from poly-b-carbonyl precursors. The strategic and mild 
preparation of those highly reactive substrates thus represents an 
essential prerequisite to transfer polyketide reactivity principles to 
develop biomimetic synthetic methods. The high reactivities of 
more complex polyketone precursors and the multitude of 
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prefold the polyketide chains. Similar to polycyclization strategies 
for other natural product families such as the terpene cyclase 
mimics,[37] selective catalytic activation modes that control the 
folding of increasingly complex substrate chains can be 
anticipated for the divergent construction of natural und new-to-
nature carbon frameworks by the cyclization of common 
polyketide intermediates.  
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The folding and cyclization of 
polyketide chains precisely controls the 
divergent biosynthesis of structurally 
distinct aromatic natural products. In 
this minireview, we highlight the virtues 
of transferring this biosynthetic concept 
into the assembly of polyaromatics and 
underline the prospects of emerging 
divergent cyclizations controlled by 
small molecules catalysts. 
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